Health inequalities are differences in health status or the distribution of health determinants between distinct populations or groups. These have important impacts on the accessibility and effectiveness of cardiovascular disease preventive measures. This article discusses the most relevant issues on this topic.
Introduction
Health inequalities are differences in health status or the distribution of health determinants between distinct populations or groups. Inequalities originate through an intertwined effect of access to resources (i.e. education, money, knowledge and power) and characteristics of the individual (i.e. age, sex and ethnicity). This combination generates an individualised pattern that influences interactions with the health care system through differences in health literacy, health-seeking behaviour and access to services, health promotion and therapeutic outcomes. 1-5 Several studies have identified a pattern in which the sickest patients get the least amount of care (also known as the 'inverse care law'), 6 emphasising how vulnerability may display predefined gradients.
Inequalities are intrinsically possible whenever resources are finite and their allocation is not formally given, but follows unspecified rules. If health care coverage is not universal, access to services will depend, among other aspects, on education and income. 4 If therapies are not standardised and priorities not regulated, allocation of newer and possibly more efficacious medications might not match the criteria of efficacy or need. 7 Whether health care should strive for equality (i.e. making the same offer accessible to all people regardless of potentially different needs) or equity (i.e. allocating means unequally based on the notion that different subpopulations have different needs) remains an open discussion with ample consequences. 8 The mechanisms that generate inequality exemplify how preventive action can happen at two levels: the individual 'agentic' level or the societal 'structural' one. 9 In recent decades, we have witnessed both increased attention towards population-wide prevention measures and a substantially market-driven trend towards individualised efforts. Growing evidence demonstrates how structural prevention strategies can reduce social inequalities, 10 while agentic strategies more frequently increase them. 11 In the following review, we will explore the impacts of several determinants of inequality on access to secondary cardiovascular prevention with a focus on lifestyle aspects, which are amenable to structural prevention, and pharmacological ones, which have to be agentic in nature.
